Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer-Reference-Cited by-同舟云学术

Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer

Published:2021-07-30 Issue:7 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Coleridge Sarah L¹,Bryant Andrew²,Kehoe Sean³,Morrison Jo⁴

Affiliation:

1. Department of Obstetrics and Gynaecology; Nottingham University Hospitals NHS Trust; Nottingham UK

2. Institute of Health & Society; Newcastle University; Newcastle upon Tyne UK

3. Institute of Cancer and Genomics; University of Birmingham; Birmingham UK

4. Department of Gynaecological Oncology; Musgrove Park Hospital; Taunton UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference211 articles.

1. Chekman C Layoune R Hocine O Raissi N Ferhat HA Ali Khodja H An open prospective randomized trial comparing primary complete cytoreduction surgery to debulking surgery after chemotherapy in advanced stage (FIGO's IIIC) ovarian carcinoma 19th International Meeting of the European Society of Gynaecological Oncology, ESGO 2015; 2015 Oct 24-27; Nice France 2015 1316

2. Fagotti A Ferrandina G Vizzielli G Fanfani F Gallotta V Chiantera V Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): final analysis of peri-operative outcome European Journal of Cancer 2016 59 22 33

3. Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850);Ferrandina;International Journal of Gynecological Cancer,2020

4. Survival analyses from a randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer with high tumor load (SCORPION trial);Fagotti;Journal of Clinical Oncology,2018

5. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial;Kehoe;Lancet,2015

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer;Cochrane Database of Systematic Reviews;2024-06-27

2. Consenso de expertos basado en la evidencia: perfilamiento y manejo del carcinoma epitelial de ovario de alto grado avanzado;Revista Colombiana de Obstetricia y Ginecología;2024-06-14

3. Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group;Frontiers in Oncology;2024-06-04

4. The malignant transformation of endometriosis: Is there a left lateral predisposition of ovarian clear cell and endometrioid carcinomas?;European Journal of Surgical Oncology;2024-06

5. Primary cytoreductive surgery followed by chemotherapy compared to neoadjuvant chemotherapy followed by cytoreduction as a treatment for stage III and IV ovarian cancer (literature review);Tumors of female reproductive system;2024-05-18